CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 6 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 21,572 | $17,000 | 0.00% |
| Hudock, Inc. | 300 | $0 | 0.00% |
| UBS Group AG | 7,725 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 45,685 | $35,000 | 0.00% |
| HRT FINANCIAL LP | 10,870 | $8,000 | 0.00% |